Device Firms Criticize FDA Proposals To Share More Pre-Market Intel
This article was originally published in The Gray Sheet
Executive Summary
Device and drug makers say FDA's draft proposals for publicly releasing more information on product applications would cripple the industry without providing much benefit to patients
You may also be interested in...
Regulatory News In Brief
FDA downclassifies tissue adhesives for wound closure
Regulatory News In Brief
FDA downclassifies tissue adhesives for wound closure
FDA Unveils 21 Policy Changes To Increase Transparency With Public
FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency